These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3290413)

  • 1. An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder.
    McBride MC
    J Pediatr; 1988 Jul; 113(1 Pt 1):137-45. PubMed ID: 3290413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate v. placebo--a randomised double-blind crossover study in children with the attention deficit disorder.
    Cotton MF; Rothberg AD
    S Afr Med J; 1988 Sep; 74(6):268-71. PubMed ID: 3047886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
    Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families.
    Kent MA; Camfield CS; Camfield PR
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1292-6. PubMed ID: 10591309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings.
    Pelham WE; Gnagy EM; Burrows-Maclean L; Williams A; Fabiano GA; Morrisey SM; Chronis AM; Forehand GL; Nguyen CA; Hoffman MT; Lock TM; Fielbelkorn K; Coles EK; Panahon CJ; Steiner RL; Meichenbaum DL; Onyango AN; Morse GD
    Pediatrics; 2001 Jun; 107(6):E105. PubMed ID: 11389303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active drug placebo trial of methylphenidate--a clinical service for children with an attention deficit disorder.
    Fine S; Jewesson B
    Can J Psychiatry; 1989 Jun; 34(5):447-9. PubMed ID: 2670175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
    Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
    J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate protocol: feasibility in a pediatric practice.
    DiTraglia J
    Clin Pediatr (Phila); 1991 Dec; 30(12):656-60. PubMed ID: 1764872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.
    Pelham WE; Bender ME; Caddell J; Booth S; Moorer SH
    Arch Gen Psychiatry; 1985 Oct; 42(10):948-52. PubMed ID: 3899046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffectiveness of imipramine in children who fail to respond to methylphenidate.
    Winsberg BG; Kupietz SS; Yepes LE; Goldstein S
    J Autism Dev Disord; 1980 Jun; 10(2):129-37. PubMed ID: 6765502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
    Brown RT; Wynne ME; Slimmer LW
    J Clin Psychiatry; 1984 Nov; 45(11):473-6. PubMed ID: 6386794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of methylphenidate and placebo on eye-hand coordination functioning and handwriting of children with attention deficit hyperactivity disorder.
    Lufi D; Gai E
    Neurocase; 2007 Oct; 13(5):334-41. PubMed ID: 18781432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD).
    Gross-Tsur V; Shalev RS; Badihi N; Manor O
    J Child Neurol; 2002 Dec; 17(12):863-6. PubMed ID: 12593456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL
    Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responders, nonresponders, and placebo responders among children with attention deficit disorder. Importance of a blinded placebo evaluation.
    Ullmann RK; Sleator EK
    Clin Pediatr (Phila); 1986 Dec; 25(12):594-9. PubMed ID: 3536258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.